Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001416229 | SCV001618408 | likely benign | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2023-08-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001692381 | SCV001913824 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341902 | SCV002641216 | likely benign | Cardiovascular phenotype | 2018-08-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV001416229 | SCV002807436 | likely benign | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2021-08-13 | criteria provided, single submitter | clinical testing |